Choi S Y, Komaromy M C, Chen J, Fong L G, Cooper A D
Research Institute, Palo Alto Medical Foundation, CA 94301.
J Lipid Res. 1994 May;35(5):848-59.
ApoE is a ligand for the low density lipoprotein (LDL) receptor as well as for the LDL receptor-related protein (LRP). The enzyme hepatic lipase (HL) may also affect the uptake of lipoproteins by modifying their composition. We have tested the hypothesis that hepatic lipase and apoE can function as co-factors to alter the rate of lipoprotein uptake. Chinese hamster ovary (CHO) cells were transfected with cDNAs for rat hepatic lipase, human apoE or both HL and apoE. The secreted recombinant proteins were thoroughly characterized and had properties identical to the native proteins. Hepatic lipase and apoE were secreted at 0.17 and 1.25 micrograms/mg cell protein per hour, rates comparable to those in normal liver. 125I-labeled LDL, chylomicron remnants, or chylomicrons were added to media at concentrations near their Kd. In cells that secreted either apoE or hepatic lipase, or both apoE and hepatic lipase, LDL binding was significantly greater than with control cells (2.2-, 2-, 2-fold greater, respectively). Similar enhancement of LDL degradation was observed. In the presence of anti-LDL receptor antibodies, these values were reduced to control levels; thus, the enhanced uptake was mediated by the LDL receptor and not the LRP. The amount of LDL receptor protein, as judged by Western blotting, was similar in the various cell types. Incubation of control CHO cells with media from secreting transfected cells also increased the uptake of 125I-labeled LDL. Kinetic studies indicated that, in apoE-secreting cells, increased LDL binding is associated with a lower Kd and an unchanged Vmax as compared to the control cells; furthermore, when LDL were reisolated by column chromatography (but not by ultracentrifugation) from the incubations where apoE was being secreted, apoE was identified adherent to the LDL particles. Together, these results suggest that the effect is due to alteration of the lipoprotein and not the cell. In contrast, the uptake of 125I-labeled chylomicron remnants, and 125I-labeled chylomicrons was not greater in the transfected cells. Thus, in the amounts secreted by these cells, hepatic lipase and apoE do not convert chylomicrons to chylomicron remnants or alter the uptake of chylomicron remnants by either the LDL receptor or the LRP. The enhancement of LDL removal in cells that secrete hepatic lipase or apoE may help determine the amount of LDL removed by a particular tissue.
载脂蛋白E(ApoE)是低密度脂蛋白(LDL)受体以及LDL受体相关蛋白(LRP)的配体。肝脂酶(HL)也可能通过改变脂蛋白的组成来影响其摄取。我们检验了肝脂酶和ApoE可作为辅助因子改变脂蛋白摄取速率的假说。用大鼠肝脂酶、人ApoE或HL与ApoE的cDNA转染中国仓鼠卵巢(CHO)细胞。对分泌的重组蛋白进行了全面表征,其性质与天然蛋白相同。肝脂酶和ApoE的分泌速率分别为每小时0.17和1.25微克/毫克细胞蛋白,与正常肝脏中的速率相当。将125I标记的LDL、乳糜微粒残粒或乳糜微粒以接近其解离常数(Kd)的浓度添加到培养基中。在分泌ApoE或肝脂酶或同时分泌ApoE和肝脂酶的细胞中,LDL结合显著高于对照细胞(分别高出2.2倍、2倍、2倍)。观察到LDL降解也有类似增强。在存在抗LDL受体抗体的情况下,这些值降至对照水平;因此,增强的摄取是由LDL受体介导的,而非LRP。通过蛋白质印迹法判断,不同细胞类型中LDL受体蛋白的量相似。用来自分泌转染细胞的培养基孵育对照CHO细胞也增加了125I标记LDL的摄取。动力学研究表明,在分泌ApoE的细胞中,与对照细胞相比,LDL结合增加与较低的Kd和不变的最大反应速度(Vmax)相关;此外,当通过柱色谱法(而非超速离心法)从分泌ApoE的孵育物中重新分离LDL时,发现ApoE附着在LDL颗粒上。总之,这些结果表明这种效应是由于脂蛋白的改变而非细胞的改变。相比之下,转染细胞中125I标记的乳糜微粒残粒和125I标记的乳糜微粒的摄取并没有增加。因此,就这些细胞分泌的量而言,肝脂酶和ApoE不会将乳糜微粒转化为乳糜微粒残粒,也不会改变LDL受体或LRP对乳糜微粒残粒的摄取。分泌肝脂酶或ApoE的细胞中LDL清除的增强可能有助于确定特定组织清除LDL的量